Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.

British journal of clinical pharmacology2005Culm-Merdek KE, von Moltke LL, Harmatz JS, et al.

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2005
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Area Under CurveCaffeineCentral Nervous System StimulantsChromatography, High Pressure LiquidCross-Over StudiesDouble-Blind MethodDrug CombinationsDrug InteractionsElectroencephalographyFemaleFluvoxamineHalf-LifeHumansMaleMiddle AgedPsychomotor PerformanceSelective Serotonin Reuptake Inhibitors

DOI 10.1111/j.1365-2125.2005.02467.x

PMID 16236038

View source →